Tumor metabolism, the ketogenic diet and β-hydroxybutyrate: novel approaches to adjuvant brain tumor therapy
Malignant brain tumors are devastating despite aggressive treatments such as surgical resection, chemotherapy and radiation therapy. The average life expectancy of patients with newly diagnosed glioblastoma is approximately ~18 months. It is clear that increased survival of brain tumor patients requ...
Main Authors: | Eric C. Woolf, Nelofer Syed, Adrienne C. Scheck |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2016-11-01
|
Series: | Frontiers in Molecular Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fnmol.2016.00122/full |
Similar Items
-
Investigating the Ketogenic Diet As Treatment for Primary Aggressive Brain Cancer: Challenges and Lessons Learned
by: Kenneth A. Schwartz, et al.
Published: (2018-02-01) -
Ketogenic diets as an adjuvant therapy in glioblastoma (the KEATING trial): study protocol for a randomised pilot study
by: Kirsty J. Martin-McGill, et al.
Published: (2017-11-01) -
Ketogenic Diet for Obesity: Friend or Foe?
by: Antonio Paoli
Published: (2014-02-01) -
Maintenance of Energy Homeostasis during Calorically Restricted Ketogenic Diet and Fasting-MR-Spectroscopic Insights from the ERGO2 Trial
by: Katharina J. Wenger, et al.
Published: (2020-11-01) -
Ketogenic diets and Alzheimer’s disease
by: Klaus W. Lange, et al.
Published: (2017-03-01)